Harvard Bioscience, Inc. (HBIO) Reports Q2 Earnings of $0.06
Tweet
Share
E-mailGet Alerts HBIO Hot Sheet
Price: $7.48 -0.93%
Financial Fact:
Diluted earnings per common share: -0.05
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Diluted earnings per common share: -0.05
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Harvard Bioscience, Inc. (NASDAQ: HBIO) reported Q2 EPS of $0.06, versus $0.08 reported last year. Revenue for the quarter came in at $28.5 million versus the consensus estimate of $27.1 million.
For earnings history and earnings-related data on Harvard Bioscience, Inc. (HBIO) click here.
For earnings history and earnings-related data on Harvard Bioscience, Inc. (HBIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- Deutsche Bank monitors UK auto sales as Chinese exports grow
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
